Alpha 2.0
Login Register
» Authors » Munawar Anwar

Munawar Anwar

Explore the profile of Munawar Anwar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 82
Followers 0
Related Specialties
Oncology
Endocrinology
Science
Top 10 Co-Authors
Dengjie Ouyang
Wenjun Yi
Qitong Chen
Yi Li
Zhi Xiao
Bo Qiu
Xiaohong Yang
Lai Li
Jing Li
Yunqi Wang
Published In
Front Oncol
Gland Surg
Clin Cancer Res
Ann Transl Med
Sci Rep
Affiliations
Soon will be listed here.
Recent Articles
1.
Prognostic value of preoperative modified Glasgow prognostic score in predicting overall survival in breast cancer patients: A retrospective cohort study
Chen Y, Zhang B, Wang X, Chen Y, Anwar M, Fan J, et al.
Oncol Lett . 2025 Feb; 29(4):180. PMID: 39990808
The modified Glasgow prognostic score (mGPS), based on C-reactive protein and albumin levels, is an inflammation-based prognostic tool used in various cancers. However, related research in breast cancer is limited....
2.
A literature review of the promising future of : a potential drug therapy target
Wen Y, Ouyang D, Zou Q, Chen Q, Luo N, He H, et al.
Ann Transl Med . 2023 Jan; 10(24):1403. PMID: 36660684
Background And Objective: Previous studies have demonstrated that the oncogene trophoblast cell surface antigen 2 () has great application prospects as a therapeutic target. However, few literature reviews have systematically...
3.
Prognostic value of tumor mutation burden and the relationship between tumor mutation burden and immune infiltration in + breast cancer: a gene expression-based study
Wen Y, Ouyang D, Chen Q, Zeng L, Luo N, He H, et al.
Gland Surg . 2022 Mar; 11(1):100-114. PMID: 35242673
Background: Whether tumor mutation burden (TMB) correlated with improved survival outcomes or promotion of immunotherapies remained controversy in various malignancies. We aimed to explore the prognostic value of TMB and...
4.
Construction and validation of a risk prediction model for clinical axillary lymph node metastasis in T1-2 breast cancer
Luo N, Wen Y, Zou Q, Ouyang D, Chen Q, Zeng L, et al.
Sci Rep . 2022 Jan; 12(1):687. PMID: 35027588
The current diagnostic technologies for assessing the axillary lymph node metastasis (ALNM) status accurately in breast cancer (BC) remain unsatisfactory. Here, we developed a diagnostic model for evaluating the ALNM...
5.
Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data
Anwar M, Chen Q, Ouyang D, Wang S, Xie N, Ouyang Q, et al.
Clin Cancer Res . 2021 Jun; 27(16):4634-4641. PMID: 34112711
Purpose: Patients with HER2-positive (HER2) metastatic breast cancer (MBC) have poor prognoses. Pyrotinib has shown promising antitumor activity in MBC to improve progression-free survival (PFS). However, findings based on real-world...
6.
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
Chen Q, Ouyang D, Anwar M, Xie N, Wang S, Fan P, et al.
Front Oncol . 2021 Mar; 11:661128. PMID: 33747972
[This corrects the article DOI: 10.3389/fonc.2020.00811.].
7.
Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
Chen Q, Ouyang D, Anwar M, Xie N, Wang S, Fan P, et al.
Front Oncol . 2020 Jun; 10:811. PMID: 32528890
Pyrotinib, an irreversible pan-ERBB inhibitor, has shown promising antitumour activity, and acceptable tolerability. This research was conducted to evaluate the actual use and effectiveness of pyrotinib in China, therefore, contributed...